p.110 抽出テキスト

Circulation. 2018;138:e272–e391. DOI: 10.1161/CIR.0000000000000549 September 25, 2018 e381 CLINICAL STATEMENTS AND GUIDELINES

S10.2-11.	 Beinder E, Grancay T, Menendez T, et al. Fetal sinus bradycardia and the long QT syndrome. Am J Obstet Gynecol. 2001;185:743–7. S10.2-12.	 Hofbeck M, Ulmer H, Beinder E, et al. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart. 1997;77:198–204. S10.2-13.	 Cuneo BF, Etheridge SP, Horigome H, et al. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. Circ Arrhythm Electrophysiol. 2013;6:946–51. S10.2-14.	 Cuneo BF, Strasburger JF, Wakai RT, The natural history of fetal long QT syndrome. J Electrocardiol. 2016;49:807–13. S10.2-15.	 Damilakis J, Theocharopoulos N, Perisinakis K, et al. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation. 2001;104:893–7. S10.2-16.	 Duncker D, Haghikia A, Konig T, et al. Risk for ventricular fibrillation

in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail. 2014;16:1331–6.

10.3 Older Patients With Comorbidities

S10.3-1.	 Kusumoto FM, Bailey KR, Chaouki AS, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e392–e414. S10.3-2.	 American Geriatrics Society Expert Panel on the Care of Older Adults

with M. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc. 2012;60:E1–E25.

10.4 Chronic Kidney Disease

S10.4-1.	 Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37. S10.4-2.	 Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882–90. S10.4-3.	 Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933–40. S10.4-4.	 Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83. S10.4-5.	 Pun PH, Al-Khatib SM, Han JY, et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014;64:32–9. S10.4-6.	 Charytan DM, Patrick AR, Liu J, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011;58:409–17. S10.4-7.	 Wong MC, Kalman JM, Pedagogos E, et al. Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease. J Am Coll Cardiol. 2015;65:1263–5. S10.4-8.	 Kusumoto FM, Bailey KR, Chaouki AS, et al. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138:e392–e414. S10.4-9.	 Pun PH, Hellkamp AS, Sanders GD, et al. Primary prevention

implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrol Dial Transplant. 2015;30:829–35.

10.5 Valvular Heart Disease

S10.6-1.	 Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline

for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–643. S10.6-2.	 Genereux P, Stone GW, O’Gara PT, et al. Natural history, diagnostic

approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2016;67:2263–88. S10.6-3.	 Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106:1355–61. S10.6-4.	 Grigioni F, Enriquez-Sarano M, Ling LH, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078–85. S10.6-5.	 Nordhues BD, Siontis KC, Scott CG, et al. Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death. J Cardiovasc Electrophysiol. 2016;27:463–8. S10.6-6.	 Basso C, Perazzolo MM, Rizzo S, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556–66. S10.6-7.	 Sriram CS, Syed FF, Ferguson ME, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic outof-hospital cardiac arrest. J Am Coll Cardiol. 2013;62:222–30. S10.6-8.	 Albert CM, Chae CU, Grodstein F, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107:2096–101. S10.6-9.	 Kannel WB, Wilson PW, D’Agostino RB, et al. Sudden coronary death in women. Am Heart J. 1998;136:205–12. S10.6-10.	 Bogle BM, Ning H, Mehrotra S, et al. Lifetime risk for sudden cardiac death in the community. J Am Heart Assoc. 2016;5:e002398. S10.6-11.	 Kim C, Fahrenbruch CE, Cobb LA, et al. Out-of-hospital cardiac arrest in men and women. Circulation. 2001;104:2699–703. S10.6-12.	 Teodorescu C, Reinier K, Uy-Evanado A, et al. Survival advantage from ventricular fibrillation and pulseless electrical activity in women compared to men: the Oregon Sudden Unexpected Death Study. J Interv Card Electrophysiol. 2012;34:219–25. S10.6-13.	 Wissenberg M, Hansen CM, Folke F, et al. Survival after out-ofhospital cardiac arrest in relation to sex: a nationwide registry-based study. Resuscitation. 2014;85:1212–8. S10.6-14.	 Bray JE, Stub D, Bernard S, et al. Exploring gender differences and the “oestrogen effect” in an Australian out-of-hospital cardiac arrest population. Resuscitation. 2013;84:957–63. S10.6-15.	 Ng YY, Wah W, Liu N, et al. Associations between gender and cardiac arrest outcomes in Pan-Asian out-of-hospital cardiac arrest patients. Resuscitation. 2016;102:116–21. S10.6-16.	 Hagihara A, Onozuka D, Hasegawa M, et al. Resuscitation outcomes of reproductive-age females who experienced out-of-hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2017;6:121–9. S10.6-17.	 Safdar B, Stolz U, Stiell IG, et al. Differential survival for men and women from out-of-hospital cardiac arrest varies by age: results from the OPALS study. Acad Emerg Med. 2014;21:1503–11. S10.6-18.	 Albert CM, McGovern BA, Newell JB, et al. Sex differences in cardiac arrest survivors. Circulation. 1996;93:1170–6. S10.6-19.	 Chugh SS, Uy-Evanado A, Teodorescu C, et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: The Ore-SUDS (Oregon Sudden Unexpected Death Study). J Am Coll Cardiol. 2009;54:2006–11. S10.6-20.	 Kim MJ, Shin SD, McClellan WM, et al. Neurological prognostication by gender in out-of-hospital cardiac arrest patients receiving hypothermia treatment. Resuscitation. 2014;85:1732–8. S10.6-21.	 Marijon E, Bougouin W, Perier MC, et al. Incidence of sportsrelated sudden death in France by specific sports and sex. JAMA. 2013;310:642–3. S10.6-22.	 Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590–7. S10.6-23.	 Higgins AY, Waks JWJosephson ME, Influence of gender on the tolerability, safety, and efficacy of quinidine used for treatment of supraventricular and ventricular arrhythmias. Am J Cardiol. 2015;116:1845–51. S10.6-24.	 Tanaka Y, Tada H, Ito S, et al. Gender and age differences in candi-

dates for radiofrequency catheter ablation of idiopathic ventricular arrhythmias. Circ J. 2011;75:1585–91.

10.7 Medication-Induced Arrhythmias

S10.7-1.	 Antman EM, Wenger TL, Butler VP Jr, et al. Treatment of 150 cases

of life-threatening digitalis intoxication with digoxin-specific Fab

Downloaded from http://ahajournals.org by on October 7, 2026